Showing results (211-220 of 566) with videos related to

Sort By:
Pageof 57
Arthritis Care & Research|December 30, 2017
Multicenter Delphi Exercise to Identify Important Key Items for Classifying Systemic Lupus ErythematosusGabriela Schmajuk, Bimba F Hoyer, Martin Aringer, et al.
The Journal of Rheumatology|May 26, 2006
Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study GroupLeslie J Crofford, Matthew D Breyer, C Vibeke Strand, et al.
The Journal of Rheumatology|August 5, 2025
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual MeetingSarah Romanelli, Beth Childs, Vibeke Strand, et al.
Frontiers in Immunology|October 9, 2023
Case Report: Response of cutaneous lupus lesions in SLE to interferon receptor blockade parallels reduction of interferon score in bloodClaudia Günther, Christine Wolf, Louisa Fennen, et al.
Annals of the Rheumatic Diseases|August 31, 2011
Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteriaChristof Iking-Konert, Martin Aringer, Jürgen Wollenhaupt, et al.
Journal of Medical Economics|March 16, 2017
Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulatorsJeroen P Jansen, Devin Incerti, Alex Mutebi, et al.
Lupus Science & Medicine|June 1, 2025
Deucravacitinib, an oral, selective, allosteric, tyrosine kinase 2 inhibitor, in patients with active SLE: efficacy on patient-reported outcomes in a phase II randomised trialMarta Mosca, Laurent Arnaud, Anca Askanase, et al.
Zeitschrift Fur Rheumatologie|March 25, 2025
[Regional differences in the distance to rheumatological specialist care in Germany]Carlo Veltri, Nora Baer, Martin Aringer, et al.
Atherosclerosis. Supplements|November 4, 2017
Serum of patients with antiphospholipid syndrome induces adhesion molecules in endothelial cellsBettina Engel, Gregor Müller, Beate Roch, et al.
Arthritis Care & Research|September 5, 2014
Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trialVibeke Strand, Gerd R Burmester, Cristiano A F Zerbini, et al.
Pageof 57